Rolf Ehrnström

Rolf Ehrnström General Information

Biography

Mr. Rolf Ehrnström serves as Partner at Ventac Capital. He serves as Board Member at Gradientech. He served as Board Member at SAGA Diagnostics. He also serves as the Chief Scientific Officer at Immunovia. He serves as the Chairman at Orbit Genomics. He has more than 30 years of scientific, technical and commercial experience from small, medium and large sized lifescience and diagnostics companies on the international arena. He serves as Partner at Ventac Partners. He has more than 30 years of scientific, technical and commercial experience from small, medium and large sized life science and diagnostics companies on the international arena. Last 20 years he served in senior executive management roles. He contributes with an extensive experience in products, technology- and strategic development in the life science and diagnostics industry. He has a track record of leading large operational organizations ( >200 staff), restructuring of large R&D organizations, integration of acquired companies as well as managing rapid growth in new startups. Much of his experience comes from leadership in multinational management teams and organizations in Scandinavia, Europe, USA and Asia. His responsibilities have ranged from all technical disciplines within R&D as well as IP, Regulatory & Medical & Clinical Affairs, Scientific Relations/Profiling and External Scientific Collaborations. In recent years a special focus has been in the fields of Personalized Medicine, companion diagnostics and technology innovation where Dako has played a leading role in its field. The last 20 years he served in senior executive management roles. He holds a MSc in biochemistry & biotechnology engineering from Royal Institute of Technology, Stockholm Sweden.